Back to Search
Start Over
Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab.
- Source :
- Medicine; 4/2/2021, Vol. 100 Issue 13, p1-6, 6p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 00257974
- Volume :
- 100
- Issue :
- 13
- Database :
- Complementary Index
- Journal :
- Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 150134842
- Full Text :
- https://doi.org/10.1097/MD.0000000000025402